Skip Ribbon Commands
Skip to main content
Menu
Clin Asst Prof Han Shuting

Clin Asst Prof Han Shuting

BA (Hons), MBBChir, MRCP (S’pore), MMed (In. Med)

Consultant

National Cancer Centre Singapore

Specialty: Medical Oncology

Sub-specialties: Gastrointestinal

Conditions Treated by this Doctor:
Anal Cancers, Bile Duct Cancer, Biliary Cancer, Colorectal Cancer, Liver Cancer, Pancreatic Cancer, Pancreatico-Biliary Diseases, Stomach (Gastric) Cancer.

Clinical Appointments

  • Consultant Division of Medical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore

Academic Appointments

  • Clinical Instructor, Duke-NUS Medical School
  • Clinical Tutor, Yong Loo Lin School of Medicine (NUS)
  • Physician faculty member, Medical Oncology Senior Residency Programme

Profile

Dr. Han Shuting is a Consultant Medical Oncologist at the National Cancer Centre Singapore (NCCS). She graduated with Bachelor of Arts (Honours) from Christ’s College, Cambridge in 2010 and Bachelor of Medicine and Surgery (MBBChir) from Cambridge School of Clinical Medicine in 2013. Subsequently, she obtained her MRCP (UK) and MMed (Int. Med) accreditation in 2015. She completed her medical oncology training in NCCS in 2019. She is currently pursuing a PhD at the National University of Singapore under the National Medical Research Council (NMRC) research training fellowship award. She sub-specialises in gastrointestinal cancers and her areas of research include colorectal cancers, viral-driven cancers and immuno-oncology.

Education

  • MA (Hons) 2019 – University of Cambridge
  • MMed (Int. Med) 2015 – National University of Singapore
  • MRCP (Singapore) 2015 – Royal College of Physicians
  • MBBChir 2013 – University of Cambridge
  • BA (Hons) 2010 – University of Cambridge

Professional Appointments and Committee Memberships

  • Co-chairperson, Chemotherapy Safety Committee 2021-2022
  • Committee Member, Singapore Cancer Society Colorectal Awareness Campaign 2021-2022
  • Committee Member, Senior Residency Education Committee 2017-2018

Awards

  • National Medical Research Council (NMRC) Research Training Fellowship 2021
  • SingHealth Quality Service Award 2021 (Silver)
  • National Cancer Centre Singapore Research Fund Award 2017-2019
  • Cambridge Overseas Trust Award 2007-2010

Research Interests

Publications

  • Single-cell and Bulk transcriptomics reveals 2 epithelial cancer subtypes that underpins the molecular classification of colorectal cancer. Nature Genetics (In press) Ignasius Joanito Irwan….Shuting Han…Shyam Prabhakar, Iain Beehuat Tan
  • Oncology workload in a tertiary hospital during the COVID-19 pandemic. Proceedings of Singapore Healthcare. June 2022. doi:10.1177/20101058211051118 Jianbang Chiang, Valerie Yang, Shuting Han, Qingyuan Zhuang, Siqin Zhou, Sachin Mathur, Mei Ling Kang, Joanne Ngeow, Swee Peng Yap, Chee Kian Tham
  • Impact of cancer diagnoses on the outcomes of patients with COVID-19 – a systematic re-view and meta-analysis. BMJ Open. 2022 Feb 7;12(2):e044661. doi: 10.1136/bmjopen-2020-044661. PMID: 35131810; PMCID: PMC8822543. Shuting Han, Qingyuan Zhuang, Jianbang Chiang, Sze Huey Tan, Gail Wan Ying Chua, Conghua Xie, Melvin Lee Kiang Chua, Yu Yang Soon, Valerie Shiwen Yang
  • Epstein-Barr Virus (EBV)-driven Epithelial Cancers – A Comprehensive Understanding to Drive Novel Therapies. Front Immunol. 2021 Dec 10;12:734293. doi: 10.3389/fimmu.2021.734293. PMID: 34956172; PMCID: PMC8702733. Shuting Han, Joshua Tay, Axel Chu, Celestine Loh, Joe Yeong, Chwee Ming Lim, Han Chong Toh
  • Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy. Nature Communications 12, 117 (2021). https://doi.org/10.1038/s41467-020-20308-8 Matt Lechner, Volker H. Schartinger, Christopher D. Steele…Shuting Han… Valerie J. Lund
  • A case series: oncology patients with pulmonary infiltrates in the COVID-19 era. Singapore Med J. 2021 Oct 31. doi: 10.11622/smedj.2021193. Epub ahead of print. PMID: 34717295. Edwin Sng, Shuting Han, Valerie SW Yang, Ban Hock Tan
  • A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs). Cancers (Basel). 2020 Nov 17;12(11):3404. doi: 10.3390/cancers12113404. PMID: 33212880; PMCID: PMC7698436. Shuting Han, Suat Ying Lee, Who-Whong Wang, Yu Bin Tan, Rachel Hui Zhen Sim, Rachael Cheong, Cherlyn Tan, Richard Hopkins, John Connolly, Wai Ho Shuen and Han Chong Toh
  • Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Thera-py in Nasopharyngeal Carcinoma. Mol Ther. 2020 Sep 30:S1525-0016(20)30497-4. Richard Hopkins, Wenwei Xiang, Damien Marlier..Shuting Han…Han Chong Toh, John Connolly
  • Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer Centre. J Cancer Policy. 2020;25:100241. Jianbang Chiang, Valerie Shiwen Yang, Shuting Han, Qingyuan Zhuang, Gideon Ooi, Iris Huili Sin, Gail Wan Ying Chua, Si Ying Tan, Claramae Shulyn Chia, Veronique Kiak-Mien Tan, Patricia Soek Hui Neo, Jin Wei Kwek, Swee Peng Yap, Ravindran Kanesvaran, Soon Thye Lim, William Ying Khee Hwang, Chee Kian Tham
  • Tailoring precision immunotherapy: coming to a clinic soon? ESMO Open 2020 Feb;5:e000631. Shuting Han, Wai Ho Shuen, Who-Whong Wang, Esdy Nazim, Han Chong Toh
  • Defining precision cellular immunotherapy – seeking biomarkers to predict and optimize out-comes of T cell therapies in cancer. Precision Cancer Medicine 2019 Aug;2 Shuting Han, Who-Whong Wang, Esdy Rozali, Han Chong Toh
  • The empowerment of all modalities against cancer. Singapore Med J 2018 Nov;58(11): 560-1. Shuting Han, Han Chong Toh.
  • Somatostatin receptor imaging in nasopharyngeal cancer. Annals of Nasopharynx Cancer 2018 Jan;2. 2-2. Wenlong Nei, Amit Jain, Fu-Qiang Wang, Kin Khor Lih, Joe Yeong, Shuting Han, Kiattisa Sommat, Mei-Kim Ang, Soong Yoke Lim, Kelvin Loke
  • Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection. Ann Oncol. 2012 Feb;23(2):421-6. Mya DH, Han ST, Linn YC, Hwang WY, Goh YT, Tan DC.

Research Trials